CRISPR Therapeutics AG

NASDAQ: CRSP
$46.06
-$0.50 (-1.1%)
Closing price September 21, 2023

Wednesday's Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Lee Jackson
3 months ago
Last Updated: 3 months ago

Friday's Top Analyst Upgrades and Downgrades: American Airlines, Broadcom, Chevron, DraftKings, Exxon Mobil, Hertz, McDonald's, Merck, Meta, Shopify and More
Friday's top analyst upgrades and downgrades included American Airlines, Broadcom, Chevron, DraftKings, Enphase Energy, EOG Resources, Exxon Mobil, First Solar, Hertz Global, LyondellBasell...
Lee Jackson
5 months ago
Last Updated: 5 months ago

Barclays Picks 2 Winners and 2 Losers After Earnings
Barclays recently issued a few calls across multiple industries picking a couple winners and a couple losers.
Chris Lange
1 year ago

Are Earnings Actually Priced In? Analysts Upgrade or Downgrade Nike, Palantir and More
Tuesday's additional top analyst upgrades and downgrades were on Bed Bath & Beyond, Clorox, CRISPR Therapeutics, LivePerson, Nike, Palantir Technologies, Tyson Foods and more.
Chris Lange
1 year ago

Will CRISPR Stock Double in the Next Year?
One big Wall Street name thinks it has found a big winner in this gene-editing company, and the stock could benefit greatly going forward.
Chris Lange
1 year ago

The Fed to the Rescue? Analysts Upgrade or Downgrade American Tower, Coinbase, Snowflake, Southwest and More
Thursday's additional top analyst upgrades and downgrades included American Tower, Coinbase, Snowflake, Southwest and more.
Chris Lange
1 year ago

Wednesday's Top Analyst Upgrades and Downgrades: eBay, EOG, Etsy, Global Payments, JPMorgan, MetLife, Otis, Salesforce, Wayfair and More
Wednesday's top analyst upgrades and downgrades included Albemarle, Camping World, eBay, EOG Resources, Etsy, Global Payments, IMAX, JPMorgan Chase, MetLife, Otis Worldwide, Salesforce, Wayfair and...
Lee Jackson
1 year ago
Last Updated: 1 year ago

Thursday's Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More
Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts, Harley-Davidson, ON Semiconductor,...
Lee Jackson
1 year ago
Last Updated: 1 year ago

Thursday's Top Analyst Upgrades and Downgrades: Airbnb, Alcoa, Beyond Meat, Marriott, Monster Beverage, Paramount, Shopify, Toast, ZoomInfo and More
Thursday's top analyst upgrades and downgrades included Airbnb, Alcoa, Beyond Meat, Fidelity National Information Services, Marriott International, Monster Beverage, Paramount Global, Shopify, Spirit...
Lee Jackson
1 year ago
Last Updated: 1 year ago

5 Sizzling 'Strong Buy' Analyst Biotechnology Picks for 2022
Biotechnology was a huge laggard last year, but Truist Securities is out with its five top picks for 2022 that could see some sensational performance this year. Portfolio managers favor these...
Lee Jackson
1 year ago

Cathie Wood's ARK Invest Buys Nearly 60,000 Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought nearly 60,000 shares of CRISPR Therapeutics on December 29 for $4.6 million.
Chris Lange
1 year ago

Tuesday Afternoon's Analyst Upgrades and Downgrades: Alibaba, Apple, Canopy Growth, Tesla and More
Tuesday afternoon's top analyst upgrades and downgrades included Alibaba, Apple, AstraZeneca, Canopy Growth, CNX Resources, Murphy Oil, Ross Stores and Tesla.
Chris Lange
1 year ago

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More
Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.
Chris Lange
1 year ago

Cathie Wood's ARK Invest Buys Over 675,000 More Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 675,000 shares of CRISPR Therapeutics on October 14.
Chris Lange
1 year ago

Cathie Wood's ARK Invest Buys Over 400,000 Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 400,000 shares of CRISPR Therapeutics on October 10.
Chris Lange
1 year ago